Supernus Pharmaceuticals' depression drug SPN-820 fails Phase 2b trial due to high placebo response, causing 20% stock drop.
Suchirindia Foundation has announced the talented and victorious winners of its 32nd National & State level science talent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback